SciSparc (SPRC) Receivables (2016 - 2025)
SciSparc (SPRC) posted Receivables of $299000.0 for Q4 2025, up 374.6% sequentially from $63000.0 in Q2 2025, and down 92.94% YoY from $4.2 million in Q4 2024.
SciSparc (SPRC) Receivables (2016 - 2025) Analysis & Trends
SciSparc has reported Receivables for 10 years, with the latest figure at $299000.0 in Q4 2025.
- Quarterly Receivables fell 92.94% year-over-year to $299000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $299000.0 (down 92.94% YoY) and the FY2025 annual result came in at $299000.0, down 92.94% from the prior year.
- Receivables advanced to $299000.0 in Q4 2025 per SPRC's latest filing, from $63000.0 in the prior quarter.
- Over five years, Receivables peaked at $5.4 million in Q4 2021 and troughed at $63000.0 in Q2 2025.
- A 5-year average of $1.5 million and a median of $710000.0 in 2023 frame the typical range for Receivables.
- The sharpest annual moves came in 2022 and 2024: Receivables tumbled 96.15% in 2022, then jumped 653.38% in 2024.
- Over 5 years, Receivables stood at $5.4 million in 2021, then sank by 96.15% to $208000.0 in 2022, then soared by 170.19% to $562000.0 in 2023, then surged by 653.38% to $4.2 million in 2024, then sank by 92.94% to $299000.0 in 2025.
- According to Business Quant data, Receivables over the past three periods registered $299000.0, $63000.0, and $4.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | SciSparc | 807,202.50 | 807,202.50 | - | 107,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 299,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Dec 31, 2024 | 4.23 Mn |
| Jun 30, 2024 | 209,000.00 |
| Dec 31, 2023 | 562,000.00 |
| Jun 30, 2023 | 858,000.00 |
| Dec 31, 2022 | 208,000.00 |
| Jun 30, 2022 | 1.32 Mn |
| Dec 31, 2021 | 5.41 Mn |
| Jun 30, 2021 | 1.46 Mn |
| Dec 31, 2020 | 777,000.00 |
| Jun 30, 2020 | 1.26 Mn |
| Dec 31, 2019 | 98,000.00 |
| Jun 30, 2019 | 492,000.00 |
| Dec 31, 2018 | 492,000.00 |
| Sep 30, 2018 | 542,000.00 |
| Jun 30, 2018 | 896,000.00 |
| Mar 31, 2018 | 411,000.00 |
| Dec 31, 2017 | 278,000.00 |
| Sep 30, 2017 | 188,000.00 |